University of Oxford
Overview
The University of Oxford is a collegiate research university that operates as an institutional investor, managing substantial endowment funds primarily through its subsidiary, Oxford University Endowment Management (OUem), and engaging in venture capital activities through its innovation arm, Oxford University Innovation.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Wild Bioscience | Jul 2026 | Series A | Co-investor |
| RQ Biotechnology Limited | Jun 2026 | Series A | Co-investor |
| Scripta Therapeutics | Nov 2025 | Seed | - |
| Wild Bioscience | Oct 2025 | Series A | Co-investor |
| Wild Biotech | Oct 2025 | Series A | Co-investor |
Key People
Aaron Jiashuo Zhang
Oxford Heart Rhythm Club Co-Founder And Co-President, Oxford University M5 Tennis Team
George Hadjipavlis FRGS FRSA
Co-Founder and Deputy Principal Investigator, The Eastern Mediterranean Programme, Research Associate - South East European Studies at Oxford (SEESOX)
Kurt Beyer
Founder Karl F. Beyer Memorial Scholarship
Leyla Najafzada
Founder Administrator
Sumeyye Kocaman
Co-Founder, Oxford Democracy Network
BUILDER REAL ESTATES AND HOTELS RESORTS AND CLINICS HOSPITALS AND DR MD GINECOLOGIST
CEO
Muneeb javaid
Managing Director
Pascal Mensah
Managing Director, Economic Policy Network
Queen San
Managing Director
Aby-Lee Adams Assoc CIPD
HR Operations Partner
Giane Stocco Boselli
Stakeholder Partner
Kaitlin Beazley
Recruitment Partner
Katrina Hadirampela
HR Partner
Morwenna Purves
HR Operations Partner
Sarah Spruytenburg Assoc CIPD
Learning Development Partner
Catherine Francis
Associate Director, Principal Gifts - Saïd Business School
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
